MicuRx Pharmaceuticals, Inc.

	Title	Date
	MICURX AND SHANGHAI ZHANGJIANG BIOMEDICAL INDUSTRY VENTURE CAPITAL PARTNER TO DEVELOP NEXT-GENERATION ANTIBIOTIC MRX-I FOR CHINESE MARKET	2012.10.26
	MICURX PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT FOR ITS NEXT-GENERATION ANTIBACTERIAL AGENT	2012.6.29
	MICURX PHARMACEUTICALS COMPLETES PHASE 1 TRIAL FOR MRX-I, A NEXT-GENERATION ANTIBIOTIC	2012.4.23
	MICURX PHARMACEUTICALS AND CUMENCOR PHARMACEUTICALS PARTNER WITH PFIZER TO DISCOVER AND DEVELOP ANTIBIOTICS FOR DRUG-RESISTANT TUBERCULOSIS IN CHINA	2010.4.6
	MICURX PHARMACEUTICALS FILES INVESTIGATIONAL NEW DRUG APPLICATION FOR MRX-I	2010.3.15
	MICURX PHARMACEUTICALS COMPLETES $10 MILLION SERIES A FINANCING TO FUND DISCOVERY AND DEVELOPMENT OF NEXT-GENERATION ANTIBIOTICS	2007.6.25

3916 Trust Way Hayward, CA 94545 USA email: zyuan@micurx.com Ph: (510) 782-2021